Table 3 Top 25 biological processes involved in late-onset fetal growth restriction.
Diseases or Functions Annotation | p value | Molecules |
|---|---|---|
Efflux of cholesterol | 4.80E−09 | ADIPOQ, APOC2, APOC3, APOE, PLTP |
Efflux of phospholipid | 4.89E−09 | APOC2, APOC3, APOE, PLTP |
Adhesion of blood cells | 1.96E−07 | ADIPOQ, APOE, FGA, GP1BA, LTF, PLTP |
Fatty acid metabolism | 2.02E−07 | ADIPOQ, APOC2, APOC3, APOE, EGFR, LTF, PLTP |
Dyslipidemia | 1.55E−06 | ADIPOQ, APOC2, APOC3, APOE |
Adhesion of immune cells | 2.49E−06 | ADIPOQ, APOE, FGA, LTF, PLTP |
Synthesis of fatty acid | 2.62E−06 | APOC2, APOC3, APOE, EGFR, LTF |
Binding of cells | 2.77E−06 | ADIPOQ, APOE, EGFR, GP1BA, LGALS3BP, LTF |
Cell movement of hepatoma cell lines | 4.84E−06 | ADIPOQ, EGFR, LYVE1, TAGLN2 |
Concentration of lipid | 6.24E−06 | ADIPOQ, APOC3, APOE, EGFR, PLTP |
Binding of blood cells | 1.40E−05 | ADIPOQ, APOE, GP1BA, LTF |
Adhesion of lymphoma cell lines | 1.66E−05 | APOE, EGFR, FGA |
Homeostasis of lipid | 1,90E−05 | APOC2, APOC3, APOE |
Adhesion of tumor cell lines | 3.28E−05 | APOE, EGFR, FGA, GP1BA, LTF |
Progression of digestive organ tumor | 3.47E−05 | APOE, EGFR |
Progression of carcinoma | 4.46E−05 | APOE, EGFR |
Binding of myeloid cells | 4.68E−05 | ADIPOQ, APOE, LTF |
Aggregation of cells | 4.83E−05 | EGFR, FGA, GP1BA, PSG2 |
Hyperlipidemia | 5.39E−05 | APOC2, APOC3, APOE |
Binding of macrophages | 6.80E−05 | ADIPOQ, APOE |
Fibrinolysis | 8.16E−05 | FGA, GP1BA |
Lower respiratory tract disorder | 9.59E−05 | EGFR, FABP5, LTF, PLTP |
Fibrin clot | 9.64E−05 | FGA, GP1BA |
Homeostasis of triacylglycerol | 9.64E−05 | APOC2, APOC3 |
Binding of fibroblasts | 1.12E−04 | APOE, LGALS3BP |
